Butterfly Network to Participate at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
Butterfly Network, Inc. (BFLY) announced participation in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference. Joseph DeVivo and Heather Getz will lead a fireside chat and one-on-one investor meetings, emphasizing their digital health innovations.
03/06/2024 - 08:30 AM
March 13, 2024
NEW YORK & BURLINGTON, Mass. --(BUSINESS WIRE)--
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that Joseph DeVivo, President, Chief Executive Officer and Chairman, and Heather Getz, Executive Vice President, Chief Financial and Operations Officer, will participate in a fireside chat and host one-on-one investor meetings at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference on March 13, 2024, at 8:40 am ET. The conference will be held virtually.
A webcast of the fireside chat will be available in the Events & Presentations section of the Butterfly investor website, and available for replay following the event until June 11, 2024.
To schedule a one-on-one meeting with Mr. DeVivo and Ms. Getz, please reach out to your Oppenheimer representative.
About Butterfly Network
Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a digital health company with a mission is to democratize medical imaging by making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly created the world's first handheld single-probe, whole-body ultrasound system using semiconductor technology, Butterfly iQ. The company has continued to innovate, leveraging the benefits of Moore’s Law, to launch its second generation Butterfly iQ+ in 2020, and third generation iQ3 in 2024 – each with increased processing power and performance enhancements. The disruptive technology has been recognized by TIME’s Best Inventions, Fast Company’s World Changing Ideas, CNBC Disruptor 50, and MedTech Breakthrough Awards, among other accolades. With its proprietary Ultrasound-on-Chip™ technology, intelligent software, and educational offerings, Butterfly is paving the way to mass adoption of ultrasound for earlier detection and remote management of health conditions around the world. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa , Asia , Australia , Europe , the Middle East , North America and South America ; to learn more about available countries, visit: butterflynetwork.com/choose-your-country.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240306046860/en/
Butterfly Investors:
investors@butterflynetwork.com
or
Neal Nagarajan
nnagarajan@sloanepr.com
Source: Butterfly Network, Inc.
When is Butterfly Network, Inc. (BFLY) participating in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference?
Butterfly Network, Inc. (BFLY) is participating in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference on March 13, 2024, at 8:40 am ET.
Who will lead the fireside chat and one-on-one investor meetings at the conference?
Joseph DeVivo, President, Chief Executive Officer and Chairman, and Heather Getz, Executive Vice President, Chief Financial and Operations Officer, will lead the fireside chat and one-on-one investor meetings at the conference.
Where can investors watch the webcast of the fireside chat?
Investors can watch the webcast of the fireside chat in the Events & Presentations section of the Butterfly investor website.
Until when will the webcast of the fireside chat be available for replay?
The webcast of the fireside chat will be available for replay following the event until June 11, 2024.
How can investors schedule a one-on-one meeting with Joseph DeVivo and Heather Getz?
Investors can schedule a one-on-one meeting with Joseph DeVivo and Heather Getz by reaching out to their Oppenheimer representative.
